Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Encode Pharmaceuticals Inc., Raptor deal

RPTP acquired Encode for 4.9 million shares valued at $2.8 million based

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE